CLINICAL_TRIALS
research
· 2026-03-24
Clinical Trial Update: Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders [NA]
Summary
This clinical trial update indicates that a study evaluating transcranial magnetic stimulation for negative symptoms in schizophrenia is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The University of Texas Health Science Center, Houston | Conditions: Schizophrenia Spectrum Disorder | NA | Status: RECRUITING